Product NDC: | 55289-110 |
Proprietary Name: | E.E.S. |
Non Proprietary Name: | Erythromycin Ethylsuccinate |
Active Ingredient(s): | 400 mg/1 & nbsp; Erythromycin Ethylsuccinate |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55289-110 |
Labeler Name: | PD-Rx Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA061905 |
Marketing Category: | ANDA |
Start Marketing Date: | 20101216 |
Package NDC: | 55289-110-09 |
Package Description: | 9 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-110-09) |
NDC Code | 55289-110-09 |
Proprietary Name | E.E.S. |
Package Description | 9 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (55289-110-09) |
Product NDC | 55289-110 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Erythromycin Ethylsuccinate |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20101216 |
Marketing Category Name | ANDA |
Labeler Name | PD-Rx Pharmaceuticals, Inc. |
Substance Name | ERYTHROMYCIN ETHYLSUCCINATE |
Strength Number | 400 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Decreased Sebaceous Gland Activity [PE],Macrolide [EPC],Macrolide Antimicrobial [EPC],Macrolides [Chemical/Ingredient] |